Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adapalene-Clindamycin Combination Gel in moderate acne vulgaris
NCT03615768Phase 3Completed
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Aug 2018
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of adapalene, clindamycin in acne vulgaris, sponsored by Lee's Pharmaceutical Holdings Limited. Started Aug 2018; status: completed.
02
Drugs
adapaleneclindamycin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT03615768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03615768.